This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked DYNC1H1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DYNC1H1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~532.4 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Testis (IHC candidate; verify WB) +4 more | |
| Negative control | Esophagus (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A03059-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | lysates from Hela, PC-3 cell line and rat brain tissue lysate (from left to right), (catalog A03059-1) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03059-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | goat anti-rabbit IgG, 1:10000 (catalog A03059-1) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
DYNC1H1 has a predicted monomer mass of 532.4 kDa; homodimerization and documented modifications are possible influences, but their effects on migration are unproven.
| Band near 532.4 kDa | consistent with the predicted DYNC1H1 monomer |
| Band near 1,065 kDa | could reflect a homodimer retained during sample preparation |
| Weak band in soluble lysate | cytoskeletal DYNC1H1 may be underrepresented in the soluble fraction |
| No distinct modification-dependent shift | the listed phosphorylation and acetylation sites do not establish a resolvable size change |
| UniProt predicted monomer mass | places the expected full-length band near 532.4 kDa |
| Homodimer formation | could yield a band near twice the monomer mass if the complex survives sample preparation |
| Documented phosphoserine and phosphothreonine sites | do not establish a resolvable change in apparent size |
| Documented acetylation sites | do not establish a resolvable change in apparent size |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | cytoskeletal DYNC1H1 may be poorly recovered | check the insoluble fraction and verify extraction |
| Band higher than expected | a homodimer may persist during sample preparation | compare denaturing conditions and confirm identity with an independent antibody |
| Band lower than expected | possible breakdown of the large DYNC1H1 chain | compare antibodies against different regions and use a depletion control |
| Weak or no signal | incomplete recovery of cytoskeletal protein | optimize extraction and check lysate loading |
| Fragments below expected size | possible breakdown of the 4,646-residue protein | prepare lysate with protease inhibitors and compare antibodies against different regions |
| Multiple bands | band identities are unresolved; the supplied record lists no named alternative isoforms | check specificity with an independent antibody or depletion control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | spermatogonia cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | Medium | Protein (IHC) | HPA → |
| Colon | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Esophagus | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
| Prostate | glandular cells | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for DYNC1H1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A03059-1 is an anti-DYNC1H1 C-terminal antibody listed for human and rat. Its WB image shows HeLa and PC-3 cell lysates and rat brain tissue lysate at 35 µg per lane, with the primary antibody diluted 1:1000. Evidence is limited to these reported samples.
Which to pick: A03059-1 is the only listed antibody and has a WB image. It is the practical choice for the shown human cell lines or rat brain tissue; the supplied evidence does not establish performance in other samples.